Virtual Reality vs Midazolam for Dacryocystorhinostomy
Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 40 (estimated)
- Sponsor
- Cairo University · Other
This trial is looking for adults who will have Dacryocystorhinostomy surgery. Participants will either use virtual reality immersion or receive Midazolam before the surgery to see which helps reduce anxiety better.
You may be able to join if
- I am between 18 and 65 years old.
- I am undergoing Dacryocystorhinostomy surgery under general anesthesia.
- I am classified as ASA I or II.
You may not be able to join if
- I refuse to participate.
- I have heart diseases.
- I have kidney diseases.
- I have allergies to medications or seizures.
- I have a history of substance abuse.
- I have claustrophobia.
- I have a cerebrovascular disease.
- I have psychiatric or cognitive disorders.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.
Loading trial locations…